US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
META
$728.08
▲+0.00%
TSLA
$370.59
▲+0.00%
AMD
$633.91
▲+0.00%
SPCX
$158.96
▲+0.00%
JNJ
$256.03
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
14.21
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
Why Iovance Biotherapeutics Tumbled by Nearly 6% Today
↗
May 16, 2025
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 16, 2025
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Kaplan Fox Alerts Investors to a Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Deadline is July 14, 2025
May 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Kaplan Fox Alerts Investors to a Securities Class Action Against Iovance Biotherapeutics, Inc. (IOVA) - Deadline is July 14, 2025
May 16, 2025
Via
TheNewswire.com
Topics
Lawsuit
Law Offices of Howard G. Smith Encourages Iovance Biotherapeutics, Inc. (IOVA) Investors to Inquire About Securities Fraud Class Action
May 16, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics
May 16, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
Rosen Law Firm Urges Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) Stockholders With Large Losses to Contact the Firm for Information About Their Rights
May 16, 2025
From
The Rosen Law Firm, P.A.
Via
Business Wire
This Foot Locker Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
↗
May 16, 2025
Via
Benzinga
IOVA CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Iovance Biotherapeutics, Inc.
May 16, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
IOVA CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit On Behalf Of Iovance Biotherapeutics, Inc. Investors
May 16, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
Iovance Biotherapeutics, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - IOVA
May 15, 2025
From
DJS Law Group
Via
Business Wire
Kaplan Fox is Investigating Potential Securities Law Violations Against Iovance Biotherapeutics, Inc. (IOVA)
May 15, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox is Investigating Potential Securities Law Violations Against Iovance Biotherapeutics, Inc. (IOVA)
May 15, 2025
Via
TheNewswire.com
Is This Beaten-Down Stock a Buy Near Its 52-Week Low?
↗
May 15, 2025
Via
The Motley Fool
IOVANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Iovance Biotherapeutics, Inc. on Behalf of Iovance Stockholders and Encourages Investors to Contact the Firm
May 13, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kaplan Fox Announces an Investigation Into Iovance Biotherapeutics, Inc. (IOVA) for Potential Securities Law Violations
May 13, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Kaplan Fox Announces an Investigation Into Iovance Biotherapeutics, Inc. (IOVA) for Potential Securities Law Violations
May 13, 2025
Via
TheNewswire.com
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
May 12, 2025
From
Glancy Prongay & Murray LLP
Via
Business Wire
3 Monster Stocks in the Making
↗
May 11, 2025
Via
The Motley Fool
Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
May 09, 2025
From
Law Offices of Howard G. Smith
Via
Business Wire
Iovance Biotherapeutics’ (IOVA) Annual Maintenance: Assurances Collide with Adverse Disclosure as Shares Plunge 44% – Hagens Berman
May 09, 2025
From
Hagens Berman
Via
Business Wire
Top movers in Friday's session
↗
May 09, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Securities Fraud Investigation Into Iovance Biotherapeutics, Inc. (IOVA) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
May 09, 2025
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Keep an eye on the top gainers and losers in Friday's session.
↗
May 09, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
May 09, 2025
Via
Benzinga
The market is filled with gapping stocks in Friday's session.
↗
May 09, 2025
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.
Via
Chartmill
Why Iovance Biotherapeutics Stock Is Crashing Today
↗
May 09, 2025
Via
The Motley Fool
Wondering what's happening in today's pre-market session?
↗
May 09, 2025
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts
↗
May 09, 2025
Via
Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
May 09, 2025
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
24
25
Next >
